[
  {
    "ts": null,
    "headline": "Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT)",
    "summary": "Key Insights Abbott Laboratories' estimated fair value is US$129 based on 2 Stage Free Cash Flow to Equity Abbott...",
    "url": "https://finnhub.io/api/news?id=7412b77f80e2060d8eebd681e2d29b123a4698a9eeabd2aa057f1142a3e4d153",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751108427,
      "headline": "Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT)",
      "id": 135623698,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights Abbott Laboratories' estimated fair value is US$129 based on 2 Stage Free Cash Flow to Equity Abbott...",
      "url": "https://finnhub.io/api/news?id=7412b77f80e2060d8eebd681e2d29b123a4698a9eeabd2aa057f1142a3e4d153"
    }
  },
  {
    "ts": null,
    "headline": "Got $500? 2 Healthcare Stocks to Buy and Hold Forever",
    "summary": "Abbott Laboratories provides exposure to multiple areas of healthcare.  The healthcare sector is an ideal place for long-term investors to focus their attention, in my view.  You won't need a fortune to get started investing in the healthcare sector.",
    "url": "https://finnhub.io/api/news?id=816f51c36c1d24fc79b428f64c3d83c9ad592e63df6495de83a65b56ff6ec14d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751104140,
      "headline": "Got $500? 2 Healthcare Stocks to Buy and Hold Forever",
      "id": 135615648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories provides exposure to multiple areas of healthcare.  The healthcare sector is an ideal place for long-term investors to focus their attention, in my view.  You won't need a fortune to get started investing in the healthcare sector.",
      "url": "https://finnhub.io/api/news?id=816f51c36c1d24fc79b428f64c3d83c9ad592e63df6495de83a65b56ff6ec14d"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum",
    "summary": "Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs. The company exceeded Wall Street expectations across its three key profitability metrics: earnings per share, adjusted gross margin, […]",
    "url": "https://finnhub.io/api/news?id=5e3e286c1ebf3109ceb9e61736b6b40db44b1b6981bbe6ae20b50a3d480107dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751088420,
      "headline": "Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum",
      "id": 135605007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs. The company exceeded Wall Street expectations across its three key profitability metrics: earnings per share, adjusted gross margin, […]",
      "url": "https://finnhub.io/api/news?id=5e3e286c1ebf3109ceb9e61736b6b40db44b1b6981bbe6ae20b50a3d480107dd"
    }
  }
]